satavaptan has been researched along with Heart Failure in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwao, H; Izumi, Y; Miura, K | 1 |
| Boerrigter, G; Burnett, JC; Costello-Boerrigter, LC | 1 |
| Haass, M | 1 |
| Villabona, C | 1 |
| Aronson, D; Krum, H; Mueller, M; Verbalis, JG | 1 |
| Konstam, MA; Udelson, JE | 1 |
| Er, F; Fuhr, U; Gassanov, N; Nia, AM; Semmo, M; Semmo, N | 1 |
| Dabrowska, MD; Krysiak, R; Okopień, B | 1 |
| Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G | 1 |
| Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P | 1 |
| Ghali, JK | 1 |
| Abassi, ZA; Abu-Saleh, N; Azzam, ZS; Bishara, B; Hoffman, A; Karram, T; Nitecki, S; Rubinstein, I; Shiekh, H; Winaver, J | 1 |
| Serradeil-Le Gal, C | 1 |
| Balding, LC; Burrell, LM; Johnston, CI; Naitoh, M; Risvanis, J | 1 |
| Martinez-Castelao, A | 1 |
12 review(s) available for satavaptan and Heart Failure
| Article | Year |
|---|---|
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
Pharmacology of vasopressin antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Benzodiazepines; Heart Failure; Humans; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2009 |
[Vasopressin receptor antagonists and heart failure].
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan | 2009 |
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Biological; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan; Water-Electrolyte Balance | 2011 |
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan | 2012 |
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins | 2003 |
Therapeutic potential of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2007 |
Mechanisms, risks, and new treatment options for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Diuretics; Heart Failure; Hospitalization; Humans; Hyponatremia; Hypovolemia; Morpholines; Prognosis; Risk Factors; Saline Solution, Hypertonic; Spiro Compounds | 2008 |
Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist.
Topics: Adenylyl Cyclases; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Deamino Arginine Vasopressin; Dogs; Heart Failure; Humans; Kidney; Morpholines; Rats; Rats, Inbred BB; Receptors, Vasopressin; Spiro Compounds; Water-Electrolyte Imbalance | 1998 |
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertension.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hypertension; Morpholines; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2000 |
SR-121463. Sanofi-Synthélabo.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Glaucoma; Heart Failure; Humans; Hypertension; Morpholines; Spiro Compounds; Structure-Activity Relationship | 2001 |
1 trial(s) available for satavaptan and Heart Failure
| Article | Year |
|---|---|
Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Body Weight; Double-Blind Method; Female; Heart Failure; Humans; Hyponatremia; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Treatment Outcome; Vasopressins; Young Adult | 2011 |
2 other study(ies) available for satavaptan and Heart Failure
| Article | Year |
|---|---|
Hyponatraemia and vasopressin in heart failure: markers or mediators?
Topics: Antidiuretic Hormone Receptor Antagonists; Heart Failure; Humans; Hyponatremia; Morpholines; Sodium; Spiro Compounds; Vasopressins | 2011 |
Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Body Weight; Cardiomegaly; Disease Models, Animal; Diuresis; Drug Administration Schedule; Heart Failure; Indoles; Kidney Function Tests; Male; Morpholines; Organ Size; Osmolar Concentration; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sodium; Spiro Compounds; Vasoconstriction | 2008 |